Top Marijuana Stocks to Watch as Federal Reform Advances

The U.S. cannabis market, projected to surpass $56 billion by 2030 from $33 billion in 2024, is gaining traction due to federal rescheduling efforts and expanding state legalization. Amid this growth, three multi-state operators are highlighted for their strategic positioning: Green Thumb Industries (GTBIF) for its scale and consistent profitability, reporting Q2 2025 revenue of $293M and $83M adjusted EBITDA; Glass House Brands (GLASF) for its California-focused, low-cost cultivation model with Q2 2025 revenue of $59.9M and 53% gross margins; and Cresco Labs (CRLBF) for its balanced retail and wholesale presence, achieving Q2 2025 revenue of $164M and $41M adjusted EBITDA. These companies are poised to benefit from industry catalysts, though investors should apply technical analysis and risk management given sector volatility.

Analysis

The U.S. cannabis sector is exhibiting strong growth fundamentals, with market sales projected to expand from $33 billion in 2024 to over $56 billion by 2030, driven by catalysts such as federal rescheduling and new state-level adult-use legalizations. Federal action, in particular, presents a significant tailwind by potentially alleviating the heavy tax burdens currently impacting operators. Within this environment, several multi-state operators (MSOs) demonstrate distinct strategic advantages. Green Thumb Industries (GTBIF) stands out for its scale and consistent profitability, reporting Q2 2025 revenue of $293 million and a strong 28% adjusted EBITDA margin, while actively returning capital to shareholders through a 5.6 million share buyback. Glass House Brands (GLASF) presents a compelling case as a low-cost, vertically integrated producer focused on the California market, achieving a 53% gross margin on $59.9 million in Q2 revenue and an impressive cultivation cost of $91 per pound. Cresco Labs (CRLBF) maintains a balanced strategy between retail and wholesale, posting $164 million in Q2 revenue and a 50.6% adjusted gross margin; despite a net loss from non-cash impairments, the company is well-positioned to capitalize on new adult-use markets like Ohio. While fundamentals appear robust across these names, the article underscores the sector's inherent volatility, necessitating disciplined risk management and the use of technical analysis to navigate price swings.

Key Decisions for Investors

• Given the positive regulatory momentum and strong growth projections, investors could consider initiating or increasing exposure to U.S. cannabis MSOs, prioritizing companies with proven profitability and operational efficiency.
• Differentiate investment theses based on company strategy: consider Green Thumb Industries for its scale and consistent profitability, Glass House Brands for its low-cost, California-focused model, and Cresco Labs for its balanced retail/wholesale approach and leverage to new markets like Ohio.
• Monitor progress on federal cannabis rescheduling closely, as any definitive action to ease tax burdens would serve as a significant catalyst for improved net profitability and a potential re-rating across the sector.
• Due to the sector's characteristic volatility, it is prudent to employ strict risk management, including scaling into positions and utilizing stop-losses, to mitigate downside risk ahead of key legislative or company-specific announcements.